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Objective: To report the prevalence and to identify factors predictive of intraocular infection 
in patients with fungemia receiving prophylactic antifungal therapy.
Methods: A retrospective review of patients who received prophylactic antifungal therapy and 
a dilated fundus examination at an academic urban tertiary care center from 2000 to 2007. Basic 
demographic information, fungal species grown, antifungal agent(s) used, number of positive 
blood culture specimens, visual acuity, visual symptoms, and known risks of disseminated can-
didiasis were noted. Logistic regression analysis was used to determine the factors significantly 
associated with intraocular fungal infection.
Results: A total of 132 patients with positive fungemia culture were requested to have ophthalmol-
ogy consults. The prevalence of ocular infection was 6.9% (N=9). All nine patients were infected 
with Candida species. Undergoing gastrointestinal (GI) surgery within the prior 6 months was 
significantly related to developing intraocular infection, with an odds ratio of 18.5 (95% confidence 
interval, 15.1–24.3; P=0.002). Having $3 positive fungal blood cultures was also a significant risk 
factor, with an odds ratio of 2.6 (95% confidence interval, 1.8–3.7; P=0.03). Among 40 patients 
having GI surgery, eight (20.0%) had intraocular fungal disease, compared with one of 92 patients 
(1.1%) not having GI surgery. Among 125 patients with a negative baseline examination result, 
two of 32 patients (6.3%), who had recent GI surgery, subsequently developed fungal ocular 
disease, compared with 0 of 93 patients (0%), who did not have recent GI surgery.
Conclusion: Recent GI surgery and higher numbers of positive fungal blood culture specimens 
may be predictive of candida ocular infections. Normal baseline fundoscopy examination results 
in patients with such risks may require repeat evaluations to detect delayed manifestations.
Keywords: fungal chorioretinitis, fungal endophthalmitis, risks factors for intraocular fungal 
infection, risks of gasterointestinal surgery
Introduction
One of the most common inpatient ophthalmology consults is for the fundoscopic 
evaluation of patients with fungemia.1,2 Candida species, in particular, are the fourth 
most common organisms identified on microbial blood stream infections in temperate 
climates of the USA and Europe.3–5 Some of the major risk factors for the development 
of candidemia are immunosuppression, indwelling catheters, total parenteral nutrition, 
and intravenous drug abuse.6–8 Ocular infection from fungemia is uncommon, but if 
present, permanent vision loss may result depending on the location and extent. The 
current recommendation from the Infectious Disease Society of America (IDSA) is to 
provide at least one dilated fundus examination to patients with positive fungal blood 
cultures.9 Chorioretinitis and endophthalmitis are the most common manifestations 
of fungemia in the eye.2,3,6 These entities were more prevalent before the widespread 
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use of prophylactic antifungal therapy, quicker laboratory 
detection of fungemia, and newer generation agents with 
greater efficacy and better side-effect profiles.10–12
A positive ophthalmic examination result in patients 
with fungemia, in addition to facilitating management of 
secondary ocular complications, establishes the diagnosis 
of disseminated candidiasis.1 However, the utility of routine 
ophthalmology consultation to rule out ocular involvement 
in patients with fungemia has been challenged by many 
authors.8,11,13–15 Although formal cost-effectiveness analyses 
on this issue are lacking, there is an increasing sentiment 
expressed in the ophthalmic literature to change the criteria 
by which an ophthalmology evaluation is requested for 
inpatients with fungemia.13,15
The reliance of visual symptoms alone results in a 
poor sensitivity (28.6%) and poor positive predictive value 
(26.7%) as the majority of patients with ocular infection may 
have no symptoms or external signs.13 The problem of rely-
ing on symptoms and external signs is compounded when 
patients are preverbal or unresponsive due to intubation or 
other medical comorbidities.8–10
With respect to patients with fungemia and specifi-
cally candidemia, there may be a subset of risk factors that 
increases the likelihood of detecting intraocular infection. 
Since the prevalence of disease affects pretest likelihood, a 
determination of the local prevalence of endogenous ocular 
fungal infections would be necessary to guide any changes 
to the screening algorithm of patients with fungemia.16
Our aims for this study were twofold: 1) to report the prev-
alence of endogenous fungal chorioretinitis/endophthalmitis 
among patients with fungemia and 2) to determine what risk 
factors among patients with fungemia place them at greater 
odds of having intraocular infection.
Methods
This study was a retrospective review conducted at the 
Virginia Commonwealth University (VCU) Medical Center 
between 2000 and 2007 that enrolled all inpatients consulted 
by the ophthalmology department to rule out ocular fungal 
infections. Consult sheets, electronic records, laboratory 
results, discharge summaries, and billing statements were 
reviewed. Patients with any prior ocular surgery, prior ocu-
lar trauma, and negative fungemia culture results, despite 
external candidal infections (ie, oral or urine infections), 
were excluded from participation. This study was approved 
by the VCU Office of Research Subjects Protection and was 
in accordance with the Declaration of Helsinki.
All abnormal fundoscopic examinations were confirmed 
by a faculty member who had undergone training in a 
vitreoretinal fellowship. Visual acuity was assessed with 
standard near cards at the bed side or Snellen charts in the 
clinic. In preverbal children, it was recorded whether or not 
they could fix and follow. When patients were intubated, 
sedated, or both, vision was recorded as unable to assess. 
An anterior segment examination was done with an external 
light source (eg, indirect ophthalmoscope with 20D lens), 
portable slit lamp, or mounted slit lamp in clinic. All dilated 
fundus examinations were performed with indirect ophthal-
moscopy. The diagnosis of fungal chorioretinitis was based 
on the description of Donahue et al11 as a deep focal, fluffy 
white lesion in the chorioretinal layers. Endophthalmitis was 
defined as vitreous involvement and further anterior exten-
sion with fluffy vitreous balls, vitreous haze, vitreous abscess, 
anterior chamber cells, or hypopyon. Basic demographic 
information was gathered along with fungal species grown, 
antifungal agent(s) used, number of positive blood culture 
specimens, visual acuity, and visual symptoms. Further, we 
documented historically reported risk factors (HRRF)6–8 for 
candidemia such as broad spectrum antibiotic use, gastroin-
testinal (GI) surgery within the previous 6 months, general-
ized immunosuppression, intravenous drug abuse, indwelling 
intravenous catheters, parenteral hyperalimentation, and 
multiple-organ involvement.
For the purposes of this study, GI surgery consisted 
of incisional surgery anywhere from the oral cavity to the 
anus as well as endoscopic procedures of this area. Etiolo-
gies of immunosuppression consisted of being on chronic 
corticosteroid therapy, routine use of immunosuppressive 
agents in patients posttransplant or with autoimmune con-
ditions, chemotherapeutic agents, and infection with HIV. 
Further, diabetes mellitus was also considered as a form 
of immune suppression. VCU Medical Center follows the 
recommendations of the IDSA and the Surgical Infection 
Society,17 regarding acquisition of specimens for potential 
blood stream infections, obtaining 20–30 mL of blood with 
2–3 bottles. If multiple sites were used to gather samples, 
they were all accessed within 1 hour of each other. If one 
of the samples was obtained from a venous catheter, then a 
separate bottle was also needed from a venipuncture site as 
the risk of contamination is higher for indwelling venous 
lines. Patients older than 2 months of age had the veni-
puncture site disinfected with chlorhexidine or 2% iodine 
tincture. Changes in the clinical picture of the patient may 
have resulted in repeat blood culture sampling, which is how 
some patients in this study could have had more than three 
bottles of blood sampled.
Besides determining the prevalence of ocular fun-
gal infection in our population, we performed a logistic 




Predictive factors of intraocular fungal infection
regression analysis to determine the possible risk factors that 
would impact the odds of having ocular involvement. The 
dependent variable was the presence of intraocular fungal 
infection (fungal chorioretinitis/endophthalmitis), and the 
independent variables were the demographic factors (Table 1) 
and the HRRF for disseminated candidemia.6–8 One variable 
was added to the model, besides the above, the proportion 
of blood culture positive specimens obtained. With these 
Table 1 Patient characteristics
N=123 (%) N=9 (%) P-value
sex
Men 72 (58.5) 4 (44.4) 0.42
Women 52 (41.5) 5 (55.6) 0.42
age, ± standard deviation (years) 37.3±25.2 51.1±17.8 0.05
age after exclude those #20 years old, none of 
whom had ocular fungal infection
45.6±19.8 51.1±17.8 0.39
race
White 49 (39.8) 4 (44.4) 0.75
Black 64 (52.0) 4 (44.4) 0.66
Other 10 (8.1) 1 (11.1) 0.79
Visual acuity (near, best corrected) N = number of eyes; 247 (%) N = number of eyes; 17 (%)
20/20–20/40 104 (42.1) 8 (47.1) 0.69
20/50–20/200 38 (15.4) 4 (23.5) 0.38
.20/200 4 (1.6) 0 0.60
Fixes and follows 24 (9.7) 0 0.18
Unable to assess 77 (31.2) 6 (35.3) 0.72
Visual symptoms (floaters, photopsias, pain, and conjunctival injection)
Present 76 (30.8) 4 (23.5) 0.74
absent 94 (38.1) 10 (58.5) 0.09
Unable to assess 77 (31.2) 3 (17.6) 0.24
Candida species grown N=123 (%) N=9 (%)
C. Albicans 50 (40.7) 6 (66.7) 0.13
C. Parapsilosis 30 (24.4) 0 0.09
C. Glabrata 22 (17.9) 2 (22.2) 0.75
C. Tropicalis 15 (12.2) 1 (11.1) 0.92
C. Lusitaniae 2 (1.6) 0 0.65
C. Krusei 2 (1.6) 0 0.65
Candida not otherwise specified 2 (1.6) 0 0.65
Prophylactic antifungal therapy useda
amphotericin B 30 (24.4) 1 (11.1) 0.36
Caspofungin 48 (39.0) 4 (44.4) 0.75
Fluconazole 61 (49.6) 5 (55.5) 0.73
Voriconazole 13 (10.6) 1 (11.1) 0.96
number using multiple antifungal agents 36 (29.2) 2 (22.2) 0.65
risk factors for disseminated candidiasisa
Broad spectrum antibiotic use 98 (79.7) 8 (77.8) 0.89
indwelling intravenous catheters 92 (74.7) 7 (66.7) 0.59
gastrointestinal surgery within the last 
6 months
32 (26.0) 8 (88.9) ,0.01
Parenteral hyperalimentation 59 (47.9) 5 (55.5) 0.33
generalized immunosuppression 63 (51.2) 6 (66.7) 0.10
Multiple-organ involvement 40 (32.5) 4 (44.4) 0.16
intravenous drug abuse 2 (0.02) 0 0.60
average number of positive blood culture 
specimens per patient
2.02 4.22 0.03
Fraction of positive blood culture specimens 0.52 0.78 0.04
intraocular pressure 14.01 13.20 0.71
Concomitant bacteremia 28 (22.6) 1 (11.1) 0.34
number of nonocular surgeries in the past year 0.86 1.55 0.07
Notes: Columns with mutual exclusively may not round to 100% due to rounding errors. aThe following columns will not add to 100% since these items were not mutually 
exclusive.





parameters defined, a backward selection technique was 
used to select the most parsimonious model as nonsignificant 
covariates were excluded. We also used multiple two-sided 
independent t-tests to compare patients with ocular infec-
tion to those without. A significance of P,0.05 was used. 
All statistical analyses were done with SAS 9.3 (2011 SAS 
Institute Inc., Cary, NC, USA).
Results
A total of 132 patients with fungemia during the study period 
had an inpatient evaluation by the ophthalmology depart-
ment. Nine of 132 patients (6.9%) had intraocular fungal 
infection. Five of these nine were female patients. Four of the 
nine were Black, four were White, and one was categorized 
as “Other” (Table 1). The mean age of patients with ocular 
infection was 51.1 years with a standard deviation of 16.8. 
Seven patients had bilateral chorioretinitis, one patient had 
chorioretinitis of the left eye only, and another had bilateral 
fungal endophthalmitis. All nine cases were infected with 
Candida species and Candida albicans grew in six patients. 
Caspofungin was used in four of the nine patients, and flu-
conazole was used in five. The patients on caspofungin were 
either already on fluconazole or later changed to fluconazole, 
upon the diagnosis of ocular candidiasis. The patient with 
endophthalmitis died 4 weeks after detection, and a patient 
with bilateral chorioretinitis died 8 weeks after detection. Four 
patients resolved with antifungal therapy alone, and three 
patients were lost to follow-up. None of the patients received 
intravitreal antifungal therapy or pars plana vitrectomy. Two 
of nine patients had normal baseline examination results and 
went on to develop positive fundoscopic findings for candidal 
involvement within 14 days. Both had recent GI surgery. In 
one of these two patients, a repeat examination was requested 
11 days later for bilateral photopsias, which ended up yield-
ing evidence of bilateral chorioretinitis. The other patient 
remained asymptomatic, and positive examination findings 
were found on routine outpatient examination 14 days after 
baseline examination. Only one other patient with ocular 
fungal disease was symptomatic, also complaining of bilateral 
photopsias but had a positive baseline examination.
A significantly greater proportion of patients with 
endogenous candidal ocular infection had recent GI surgery 
compared to those without ocular infection (88.9% vs 26.0%, 
P,0.01). Compared to patients without fungal eye disease, 
the mean fraction of positive blood culture specimens was 
significantly higher among patients with fungal eye disease 
(0.78 vs 0.52, P=0.04). Some differences between those with 
ocular infection compared to those without ocular involve-
ment approached significant levels, such as the number of 
nonocular surgeries (1.55 vs 0.86, P=0.07) and generalized 
immune suppression (66.7% vs 51.2%, P=0.10). C. albicans 
represented 40.7% of the species among patient without 
intraocular infection and 66.7% of patients with intraocular 
infection. However, the type of Candida species did not 
impact the risk of developing ocular infection (Tables 1 
and 2). Fluconazole was used in 66 of 132 of our patients, yet 
the type of antifungal agent used in patients with fungemia 
did not significantly impact the development of intraocular 
fungal infection. In the logistic regression analysis, only three 
factors significantly affected the fit of the model regarding 
the presence of ocular fungal infection (Table 2). Patients 
who had undergone GI surgery within the last 6 months were 
at an 18.5 times higher odds of developing ocular fungal 
infection compared to those who did not have GI surgery 
in the last 6 months (P=0.002). Patients who had grown $3 
positive blood culture specimens were at a 2.6 times higher 
odds of developing ocular fungal infection compared to 
those with #2 positive specimens (P=0.03). The fraction of 
positive blood culture specimens was also associated with 
the presence of ocular fungal infection. When three-quarters 
or more of the blood cultures were positive, the odds of hav-
ing ocular candidal infection were more than twice as high 
(P=0.04). None of the remaining HRRF for candidiasis had 
an impact on intraocular candidal infection.
Table 2 Factors impacting ocular Candida infection in the multivariate logistic regression model
Odds ratio (95% confidence intervals) P-value
gastrointestinal surgery
none in prior 6 months (reference) – –
One or more in the prior 6 months 18.5 (15.1–24.3) 0.002
number of positive Candida blood cultures 
#2 (reference) – –
$3 2.6 (1.8–3.7) 0.03
Fraction of positive blood culture specimens
,0.75 (reference) – –
$0.75 2.4 (1.2–3.1) 0.04
Notes: Odds ratios and 95% confidence intervals for the covariates associated with an increased risk of intraocular fungal infection. P-values are from the χ2 tests.
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Discussion
In accordance with the recommendations of the IDSA, all 
patients with fungemia at our institution receive at least one 
dilated eye examination.9 Moreover, some reports state that up 
to 18% of ocular candidal infections have negative baseline fun-
doscopy examinations.18 The time from a negative fundoscopy 
examination to visible ocular fungal lesions has ranged from 
8 days to several weeks.19–21 Given the chance of delayed pre-
sentation, we repeat a dilated fundus examination at 4–6 weeks 
if the baseline fundoscopy examination is negative.
The prevalence of ocular fungal infection in our population 
was 6.9%. All cases were from Candida species. Although this 
figure is higher than some recent studies, this prevalence seems 
to be in line with several contemporary reports that demonstrate 
values from 2% to 16%.1,2,8,12,15,22,23 The prevalence of current 
reports is lower than historical reports (35%–45%).19,24–26 
This is largely due to the initiation of prophylactic antifungal 
therapy for all positive blood cultures.15,19,22–26
Many authorities are questioning the utility of ophthalmic 
examination for patients with fungemia since now there is 
quicker laboratory detection of fungal blood specimens prompt-
ing the use of antifungal agents, which have greater efficacy 
and better side-effect profiles compared to decades ago.8,11,13–15 
Furthermore, some authors assert that patients with endogenous 
spread of fungal disease to the eye are at higher risk of mortal-
ity, and an ocular examination may add to the cost of end of 
life care. Oude Lashof et al12 reported the 14-week mortality of 
patients with endogenous candidal endophthalmitis to be 50%, 
while that in ocular candidiasis, which was not classified as 
endophthalmitis, was 43.3%. The latter values were not signifi-
cantly higher than the 14-week mortality rate for patients with 
candidemia but without ocular infection, 36.5% (P=0.31).
Moreover, because of these advances along with the 
higher mortality among patients with fungemia, the man-
agement is reported to rarely change even after fundoscopic 
evidence of ocular infection. Ghodasra et al13 estimated that 
an average of 26.4 patients with fungemia would need to 
be evaluated, at an average cost of 5,620.33 US Dollars per 
patient, in order to find one needing a change in management. 
This money value was based on the Centers of Medicare and 
Medicaid Services 2014 Physician Fee Schedule.27 These 
authors, among many others, are reassessing the utility of 
fundoscopic examinations for patients with fungemia.
However, given the potentially negative visual outcome of 
intraocular fungal infections, eliminating the need for fundo-
scopic examinations altogether may be premature. Perhaps, there 
are a unique set of risk factors that would raise the pretest likeli-
hood, or better stated, the pre-fundoscopy examination likelihood 
of a patient with candidemia to have ocular involvement.
Our study demonstrated that of the HRRF, only recent 
GI incisional or endoscopic surgery was significantly associ-
ated with ocular candidal infection (odds ratio, 18.5; 95% 
confidence interval, 15.1–24.3; P=0.002). It is possible that 
Candida species that are commensal with the GI tract could 
gain access to the blood stream in high enough inoculations 
to cause systemic disease.
A higher number of positive candidal blood culture 
specimen bottles also strongly correlated with the presence 
of intraocular infection. Having $3 positive culture bottles 
increased the odds of ocular infection compared to those 
with #2 positive culture bottles. Greater numbers of positive 
culture specimens may be a marker for larger fungal inocula-
tion, or in the circumstance of delayed specimen collection by 
a few days, it could represent a virulent organism and/or an 
immunocompromised host. This may predispose the patient to 
disseminated fungal disease. The fraction of positive culture 
bottles can also be understood by the above statements.
There are several noteworthy limitations to our study. 
First, only patients suspected of having abnormal fundus 
examinations based on an evaluation by a resident ophthal-
mologist were subjected to a confirmatory examination by 
a vitreoretinal specialist. It is possible that patients deemed 
as having normal fundus examinations may have had subtle 
retinal lesions that a novice examiner may have overlooked. 
Although our policy was to have outpatient follow-up for 
inpatients not seen by an attending physician, not all patients 
were able to make such appointments.
Second, many patients with fungemia, especially those 
with disseminated disease, may be in critical condition. It is 
possible that we did not evaluate all patients with fungemia as 
they may have had significant comorbidities that took prece-
dence over ophthalmic consultation or were deceased before 
such consultation could take place. These patients by virtue 
of their aggressive disease could have been significantly 
different from the patients who had been evaluated by the 
ophthalmology service. Finally, the nature of retrospective 
investigations lends itself to inconsistencies in documenta-
tion, which leads to suboptimal data entry for analysis.
In conclusion, this study demonstrated the prevalence of 
intraocular infection to be 6.9% among patients with fungemia 
in our urban academic medical center. Many clinicians are 
reevaluating the utility of inpatient ophthalmology consults on 
patients with fungemia. However, we feel that missing positive 
cases increases the risk of morbidity to the eye, especially in 
cases of asymptomatic endophthalmitis, and mortality to the 
patient13 by missing the chance to establish a diagnosis of dis-
seminated candidiasis. The presence of certain risk factors may 
raise the likelihood of a patient with fungemia, and candidemia 
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in particular, of having ocular infection. This study showed 
that patients having GI surgery within the last 6 months, hav-
ing $3 positive candida blood culture specimens, and having 
positive Candida blood cultures in $0.75 of specimens col-
lected, may all increase the risk of ocular candidal infection, 
and thereby warrant greater scrutiny. When patients with such 
risk factors have negative baseline fundoscopic examinations, 
ophthalmologists may wish to perform repeat examinations 
within 2 weeks to detect delayed onset disease as is the current 
practice at our institution. For patients without such risks, the 
need for repeat fundoscopic examinations may continue to be 
at the discretion of the clinician on a case-by-case basis. Lastly, 
prospective research is necessary to determine which other 
risk factors are significantly associated with ocular infection, 
thus may be identified as predictive factors and may better 
guide clinical decision-making when reconsidering screening 
algorithms for patients with fungemia.
Disclosure
The authors report no conflicts of interest in this work.
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